AnaptysBio Inc (ANAB)
25.06
-0.40
(-1.59%)
USD |
NASDAQ |
May 17, 16:00
25.06
0.00 (0.00%)
After-Hours: 19:59
AnaptysBio Cash from Investing (Quarterly): 68.62M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 68.62M |
| December 31, 2023 | 49.18M |
| September 30, 2023 | 30.64M |
| June 30, 2023 | -20.46M |
| March 31, 2023 | 85.40M |
| December 31, 2022 | 21.50M |
| September 30, 2022 | -32.43M |
| June 30, 2022 | -71.00M |
| March 31, 2022 | -312.91M |
| December 31, 2021 | -66.69M |
| September 30, 2021 | 10.84M |
| June 30, 2021 | 37.96M |
| March 31, 2021 | 56.73M |
| December 31, 2020 | 3.598M |
| September 30, 2020 | 4.732M |
| June 30, 2020 | 75.39M |
| March 31, 2020 | 10.75M |
| December 31, 2019 | 4.035M |
| September 30, 2019 | 59.86M |
| Date | Value |
|---|---|
| June 30, 2019 | 57.88M |
| March 31, 2019 | 9.657M |
| December 31, 2018 | -166.15M |
| September 30, 2018 | 24.62M |
| June 30, 2018 | -3.062M |
| March 31, 2018 | 2.146M |
| December 31, 2017 | -153.06M |
| September 30, 2017 | -0.495M |
| June 30, 2017 | -62.42M |
| March 31, 2017 | -27.08M |
| December 31, 2016 | -0.001M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | -0.014M |
| March 31, 2016 | -0.035M |
| December 31, 2015 | -0.042M |
| September 30, 2015 | -0.084M |
| June 30, 2015 | -0.032M |
| March 31, 2015 | -0.08M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-312.91M
Minimum
Mar 2022
85.40M
Maximum
Mar 2023
3.680M
Average
16.17M
Median
Cash from Investing (Quarterly) Benchmarks
| XOMA Corp | -7.246M |
| Fate Therapeutics Inc | 17.31M |
| Ocular Therapeutix Inc | -0.255M |
| Apellis Pharmaceuticals Inc | -0.293M |
| Sutro Biopharma Inc | 64.10M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -37.25M |
| Cash from Financing (Quarterly) | -13.63M |
| Free Cash Flow | -134.14M |
| Free Cash Flow Per Share (Quarterly) | -1.391 |
| Free Cash Flow to Equity (Quarterly) | -37.28M |
| Free Cash Flow Yield | -20.09% |